Palvella Therapeutics (PVLA) Share-based Compensation Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 10.78% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.55% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.65% |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | 56.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56.31% |
| Dec 31, 2025 | 29.98% |
| Sep 30, 2025 | 22.49% |
| Jun 30, 2025 | 3.27% |
| Mar 31, 2025 | -2.44% |
| Dec 31, 2024 | -41.23% |
| Sep 30, 2024 | -47.43% |
| Jun 30, 2024 | -45.30% |
| Mar 31, 2024 | -50.43% |
| Dec 31, 2023 | -58.14% |
| Sep 30, 2023 | -11.55% |
| Jun 30, 2023 | -5.38% |
| Mar 31, 2023 | -11.68% |
| Dec 31, 2022 | -5.20% |
| Sep 30, 2022 | -13.75% |
| Jun 30, 2022 | -3.59% |
| Mar 31, 2022 | -2.98% |
| Dec 31, 2021 | 1.08% |
| Sep 30, 2021 | 1.50% |
| Jun 30, 2021 | -0.62% |
| Mar 31, 2021 | 6.10% |
| Dec 31, 2020 | 2.69% |
| Sep 30, 2020 | 29.02% |
| Jun 30, 2020 | 30.24% |
| Mar 31, 2020 | 19.49% |
| Dec 31, 2019 | 32.52% |
| Sep 30, 2019 | 50.41% |
| Jun 30, 2019 | 33.39% |
| Mar 31, 2019 | 51.86% |
| Dec 31, 2018 | 75.35% |
| Sep 30, 2018 | 57.11% |
| Jun 30, 2018 | 71.46% |
| Mar 31, 2018 | 47.78% |